Inhibitory Receptors and Pathways of Lymphocytes: The Role of PD-1 in Treg Development and Their Involvement in Autoimmunity Onset and Cancer Progression

about

Inhibitory Receptors and Pathways of Lymphocytes: The Role of PD-1 in Treg Development and Their Involvement in Autoimmunity Onset and Cancer Progression

Item

http://www.wikidata.org/entity/Q58606344

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Inhibitory Receptors and Pathw ...... y Onset and Cancer Progression

@en

Inhibitory Receptors and Pathw ...... y Onset and Cancer Progression

@nl

type

Item

label

Inhibitory Receptors and Pathw ...... y Onset and Cancer Progression

@en

Inhibitory Receptors and Pathw ...... y Onset and Cancer Progression

@nl

prefLabel

Inhibitory Receptors and Pathw ...... y Onset and Cancer Progression

@en

Inhibitory Receptors and Pathw ...... y Onset and Cancer Progression

@nl

P1476

Inhibitory Receptors and Pathw ...... y Onset and Cancer Progression

@en

P2093

Alessandra Fierabracci

http://www.w3.org/2001/XMLSchema#string

Elena Gianchecchi

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production

Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death

The human PD-1 gene: complete cDNA, genomic organization, and developmentally regulated expression in B cell progenitors

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

The PD-1 pathway in tolerance and autoimmunity

The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice

Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3

Current status and perspectives in translational biomarker research for PD-1/PD-L1 immune checkpoint blockade therapy

Adaptive Immune Resistance: How Cancer Protects from Immune Attack

Co-occurring genomic alterations define major subsets of KRAS-mutant lung adenocarcinoma with distinct biology, immune profiles, and therapeutic vulnerabilities.

P304

2374

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.3389/FIMMU.2018.02374

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2018-10-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30386337

http://www.w3.org/2001/XMLSchema#string

P921

membrane proteins

hemic and immune systems

Achyolli

P932

6199356

http://www.w3.org/2001/XMLSchema#string